346 related articles for article (PubMed ID: 23104306)
1. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
Patel KK; Kumar P; Thakkar HP
AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306
[TBL] [Abstract][Full Text] [Related]
2. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
[No Abstract] [Full Text] [Related]
4. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
5. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
6. Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in melasma patients.
Kandil SM; Soliman II; Diab HM; Bedair NI; Mahrous MH; Abdou EM
Drug Deliv; 2022 Dec; 29(1):534-547. PubMed ID: 35156490
[TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.
El-Menshawe SF; Hussein AK
Pharm Dev Technol; 2013; 18(4):779-86. PubMed ID: 21913880
[TBL] [Abstract][Full Text] [Related]
8. Assessment of simvastatin niosomes for pediatric transdermal drug delivery.
Zidan AS; Hosny KM; Ahmed OA; Fahmy UA
Drug Deliv; 2016 Jun; 23(5):1536-49. PubMed ID: 25386740
[TBL] [Abstract][Full Text] [Related]
9. Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.
Aziz DE; Abdelbary AA; Elassasy AI
Curr Drug Deliv; 2018; 15(9):1330-1342. PubMed ID: 29921206
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
11. Sustained transdermal delivery of human growth hormone from niosomal gel:
Wang L; Wei L; Long W; Zhang Q; Zou Y
J Biomater Sci Polym Ed; 2022 Jun; 33(9):1198-1212. PubMed ID: 35192434
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
13. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV.
Ansari H; Singh P
Curr HIV Res; 2018; 16(4):270-279. PubMed ID: 30246641
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
Kassem AA; Abd El-Alim SH; Asfour MH
Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194
[TBL] [Abstract][Full Text] [Related]
15. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
Sharma A; Singh AP; Harikumar SL
Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
[No Abstract] [Full Text] [Related]
16. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
Soliman OAE; Mohamed EA; Khatera NAA
Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
[TBL] [Abstract][Full Text] [Related]
17. Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation.
Kaur K; Jain S; Sapra B; Tiwary AK
Curr Drug Deliv; 2007 Oct; 4(4):276-82. PubMed ID: 17979648
[TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity.
Gupta A; Singh S; Kotla NG; Webster TJ
Int J Nanomedicine; 2015; 10():171-82. PubMed ID: 25565812
[TBL] [Abstract][Full Text] [Related]
19. Development of an optimized avanafil-loaded invasomal transdermal film: Ex vivo skin permeation and in vivo evaluation.
Ahmed OAA; Badr-Eldin SM
Int J Pharm; 2019 Oct; 570():118657. PubMed ID: 31491483
[TBL] [Abstract][Full Text] [Related]
20. Optimization of propofol loaded niosomal gel for transdermal delivery.
Zhang W; Zhao X; Yu G; Suo M
J Biomater Sci Polym Ed; 2021 May; 32(7):858-873. PubMed ID: 33538243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
